InvestorsHub Logo
Followers 12
Posts 1726
Boards Moderated 1
Alias Born 09/06/2016

Re: lowlowz post# 90415

Sunday, 08/09/2020 1:55:25 PM

Sunday, August 09, 2020 1:55:25 PM

Post# of 97093

that already has FDA approved products for diabetes.


They have never successfully completed their own regulatory submission. One was completed by the company whose assets they acquired through litigation and toll manufctured by a South Korean partner. Another is a rebadged Chinese manufactured product and the 510K is that of the chinese OEM company.


Using the same technology / methodology Pharmatech Solutions claims to have created a new test strip capable of instead testing for the Covid-19 virus (antigen)



They are lying.

If DECN successfully creates this product


It can't and won't. The technology is unfeasible.

I hope DECN's claims are true.


They aren't. Berman has an established track record of over promising and under delivering. As well as diluting shareholders to waste in the process with share issues and reverse splits while insiders and Berman associated are featherbedded and issued discounted options.